Following Through On Prior Plan, Genzyme Sells Off Genetic Testing Unit
Sale of Genzyme Genetics for $925 million to LabCorp seen as enhancing the biotech's potential purchase value.
Sale of Genzyme Genetics for $925 million to LabCorp seen as enhancing the biotech's potential purchase value.